Article Abstract

Inhibition of MEK, a canonical KRAS pathway effector in KRAS mutant NSCLC

Authors: Rafael Rosell, Niki Karachaliou, Carles Codony-Servat, Masaoki Ito

Abstract

KRAS mutant NSCLC cells require active nuclear export of Iκβα (also known as NFKBIA), a negative regulatory protein of NF-κB signaling, for maintaining survival signaling (1-3). Nuclear export receptor XPO1 correlates with KRAS mutation status.